Selective estrogen receptor modulators for osteoporosis

Kanis J, McCloskey E, Cooper C, Barlow D, Brazier J
Record ID 32010000421
Authors' objectives: The aims of this project are to: Assemble published and unpublished information available on raloxifene in osteoporosis, cardiovascular disease, venous thromboembolic events and breast cancer. Evaluate the potential clinical impact of raloxifene on relevant end-points with a critical analysis of the assumptions made. To develop and apply models for cost effectiveness of raloxifene targeted for use in the prevention and treatment of osteoporosis.
Project Status: Completed
Year Published: 1999
Requestor: NIHR Health Technology Assessment programme
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: England, United Kingdom
MeSH Terms
  • Osteoporosis
  • Selective Estrogen Receptor Modulators
  • Raloxifene Hydrochloride
  • Bone Density Conservation Agents
  • Models, Economic
Organisation Name: NIHR Health Technology Assessment programme
Contact Address: NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
Contact Email:
Copyright: Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.